1037 ET - Hims & Hers Health logged heavy revenue gains in 3Q in part from its compounded weight-loss drug business, but the company's core telehealth business looked strong too, Piper Sandler analysts Korinne Wolfmeyer and Sarah Morin say in a research note. Management called out strong demand across the Hers platform, which focuses on women's health and personal care, as well as rising demand for personalized offerings and medications that treat multiple conditions at once, the analysts say. Stripping out the weight-loss business, the company's subscriber count in 3Q was still more than 40% higher year-over-year. (dean.seal@wsj.com)

(END) Dow Jones Newswires

November 05, 2024 10:37 ET (15:37 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.